Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06903013

Post Operative Pain Following Pulpectomy Versus Pulpotomy in Primary Molars Wit Irreversible Pulpitis

Study will evaluate and compare post operative pain for primary molars with irreversible pulpitis after pulpotomy and pulpuectomy

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

4 year–10 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy individual
  • Has primary tooth with irreversible pulpitis
  • Cooperative child

Exclusion criteria

  • Mentally, physically or medically compromised children
  • Uncooperative children

Treatment and study plan

Non vitalPulp therapy

Other

Pulp therapy deals about management of inflamed vital dental pulp With complete pulp removal and obturation with resorbable materi

Vital pulp therapy

Other

Pulp therapy through partial root removal and using of regenerative capping material

Primary outcomes

  1. Post operative pain

    Time frame: 6 months

    Post operative pain using pain scale after 1,2,7 days

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Official study title

Post Operative Pain Following Pulpectomy Versus Pulpotomy in Primary Molars Wit Irreversible Pulpitis a Parallel Randomized Clinical Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 30, 2025
Registry last updated
Mar 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.